跳至主要内容
临床试验/NL-OMON32731
NL-OMON32731尚未招募2 期

Effect of bezafibrate on very long chain fatty acid (VLCFA) metabolism in men with X-linked adrenoleukodystrophy. - BEZA

Academisch Medisch Centrum0 个研究点目标入组 8 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - 18 years of age or older
  • - mentally competent and able to give informed consent and able to visit the hospital for follow-up
  • - no contra-indications for the use of the trial medication (kidney- and/or liver failure)
  • - confirmed diagnosis of X-ALD (by ABCD1 mutation analysis or abnormal plasma VLCFA)

排除标准

  • - Use of other medication that influences plasma cholesterol and/or triglycerid levels (for instance drugs of the statin class)
  • - Liver disease or increased CK (> 3 times upper limit of normal)
  • - Treament with VLCFA lowering agent (i.e. Lorenzo's oil).
  • - Unable to give informed consent

研究者

相似试验